These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 387221)

  • 21. Differential cytotoxicity and DNA cross-linking in normal and transformed human fibroblasts treated with cis-diamminedichloroplatinum(II).
    Erickson LC; Zwelling LA; Ducore JM; Sharkey NA; Kohn KW
    Cancer Res; 1981 Jul; 41(7):2791-4. PubMed ID: 7195771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
    Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC
    Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.
    Micetich K; Zwelling LA; Kohn KW
    Cancer Res; 1983 Aug; 43(8):3609-13. PubMed ID: 6683124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The formation of DNA interstrand cross-links by a novel bis-[Pt2Cl4(diminazene aceturate)2]Cl4.4H2O complex inhibits the B to Z transition.
    González VM; Fuertes MA; Jiménez-Ruíz A; Alonso C; Pérez JM
    Mol Pharmacol; 1999 Apr; 55(4):770-7. PubMed ID: 10101036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D; Jenkins WT; Meyn RE
    Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
    Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
    Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
    Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA; Hosking LK; Hill BT
    Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro.
    Malfoy B; Hartmann B; Macquet JP; Leng M
    Cancer Res; 1981 Oct; 41(10):4127-31. PubMed ID: 7197193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer activity of cis-dichlorodiammineplatinum(II) and some relevant chemistry.
    Rosenberg B
    Cancer Treat Rep; 1979; 63(9-10):1433-8. PubMed ID: 498145
    [No Abstract]   [Full Text] [Related]  

  • 32. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
    J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competitive reactions of interstrand and intrastrand DNA-Pt adducts: A dinuclear-platinum complex preferentially forms a 1,4-interstrand cross-link rather than a 1,2 intrastrand cross-link on binding to a GG 14-mer duplex.
    Berners-Price SJ; Davies MS; Cox JW; Thomas DS; Farrell N
    Chemistry; 2003 Feb; 9(3):713-25. PubMed ID: 12569464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer.
    Alvarez MV; Cobreros G; Heras A; Lopez Zumel MC
    Br J Cancer Suppl; 1978 Jun; 3():68-72. PubMed ID: 277260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chemical and biological effects of cis-dichlorodiammineplatinum (II), an antitumor agent, on DNA.
    Munchausen LL
    Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4519-22. PubMed ID: 4548188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.
    Drewinko B; Gottlieb JA
    Cancer Chemother Rep; 1975; 59(3):665-73. PubMed ID: 1203891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro characterization of interstrand cross-links in DNA exposed to the antitumor drug cis-dichlorodiammineplatinum(II).
    Deutsch WA; Spiering AL; Newkome GR
    Biochem Biophys Res Commun; 1980 Dec; 97(3):1220-6. PubMed ID: 6781501
    [No Abstract]   [Full Text] [Related]  

  • 38. The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.
    Melvik JE; Dornish JM; Pettersen EO
    Br J Cancer; 1992 Aug; 66(2):260-5. PubMed ID: 1503898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin: synthesis, antitumour activity and mechanism of action.
    Reedijk J; Lohman PH
    Pharm Weekbl Sci; 1985 Oct; 7(5):173-80. PubMed ID: 3906559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid cross-linking of an RNA internal loop by the anticancer drug cisplatin.
    Hostetter AA; Chapman EG; DeRose VJ
    J Am Chem Soc; 2009 Jul; 131(26):9250-7. PubMed ID: 19566097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.